{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:44:48Z","timestamp":1792698288106,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdcr.2021.08.026","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:56:22Z","timestamp":1630450582000},"page":"134-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A case of pretibial myxedema treated with teprotumumab"],"prefix":"10.1016","volume":"16","author":[{"given":"Lauren","family":"Petit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Catinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdcr.2021.08.026_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D38ND2C6TR","article-title":"Successful combined pentoxifylline and intralesional triamcinolone acetonide treatment of severe pretibial myxedema","volume":"13","author":"Engin","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2021.08.026_bib2","series-title":"Dermatology","article-title":"Mucinosis","author":"Bolognia","year":"2018"},{"issue":"5","key":"10.1016\/j.jdcr.2021.08.026_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1365-2133.2000.03850.x","article-title":"Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts","volume":"143","author":"Shinohara","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2021.08.026_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-14-0712","article-title":"Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study","volume":"172","author":"Sisti","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"18","key":"10.1016\/j.jdcr.2021.08.026_bib5","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotubmumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jdcr.2021.08.026_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jdcr.2020.09.003","article-title":"Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease","volume":"6","author":"Varma","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jdcr.2021.08.026_bib7","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.jdcr.2021.08.026_bib8","doi-asserted-by":"crossref","first-page":"E1635","DOI":"10.1210\/jc.2014-1580","article-title":"Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jdcr.2021.08.026_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/jid.1949.53","article-title":"Local injections of a preparation of hyaluronidase in the treatment of localized (pretibial) myxedema","volume":"12","author":"Grais","year":"1949","journal-title":"J Invest Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621006044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621006044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:58Z","timestamp":1762474978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621006044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":9,"alternative-id":["S2352512621006044"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.08.026","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of pretibial myxedema treated with teprotumumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}